Taysha Gene Therapies Stock Down 1.7 % Shares of NASDAQ:TSHA opened at $1.72 on Tuesday. The company has a current ratio of 5.51, a quick ratio of 5.51 and a debt-to-equity ratio of 0.48. The ...

Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.35 per share a year ago.

1 Day TSHA -2.79% DJIA -0.62% Russell 2K -0.89% Health Care/Life Sciences -1.14% ...

We recently shared a list of 10 Best Short Squeeze Stocks To Buy According to Analysts. In this article, we will see how Taysha Gene Therapies, Inc. (NASDAQ:TSHA) compares to the other top short ...